Stay updated on Psilocybin Bioavailability in Adult Clinical Trial
Sign up to get notified when there's something new on the Psilocybin Bioavailability in Adult Clinical Trial page.

Latest updates to the Psilocybin Bioavailability in Adult Clinical Trial page
- Check4 days agoChange DetectedAdded a site-wide notice about government funding and operating status with status links, and updated the page version to v3.4.1, removing v3.4.0.SummaryDifference0.5%

- Check11 days agoChange DetectedShow glossary option added and the QC status label updated to 'Last Update Submitted that Met QC Criteria'. The revision footer now shows 'Revision: v3.4.0' with capitalization changes such as 'No FEAR Act Data'.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision log updated to add Revision: v3.3.4 and remove Revision: v3.3.3.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded a dedicated Locations section and the Wisconsin site (Madison, WI) to the study page. Removed the Wisconsin Locations entry and the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check76 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no changes to study details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedRemoved the government funding lapse notice from the study page, which previously warned that information may not be up to date and that certain operations could be affected.SummaryDifference0.4%

Stay in the know with updates to Psilocybin Bioavailability in Adult Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin Bioavailability in Adult Clinical Trial page.